NIH Reporter #1R15HL165328-01A1

NHLBI Research Grant: Obesity-Related Hypertension, PPAR Gamma Acetylation, and Asprosin

This opportunity is a research grant solicitation from the National Heart Lung and Blood Institute (NHLBI), part of the NIH, focused on obesity-related hypertension and the roles of PPAR gamma acetylation and asprosin. - Government Buyer: - National Heart Lung and Blood Institute (NHLBI), National Institutes of Health (NIH) - Located in Old Westbury, NY - Products/Services Requested: - Research project investigating PPAR gamma acetylation and asprosin in obesity-related hypertension - Utilizes in vivo, ex vivo, and in vitro research methods - Open to Schools of Osteopathic Medicine and basic sciences departments - OEMs and Vendors: - No specific OEMs or vendors are named, as this is a research grant - Unique/Notable Requirements: - Project must address the mechanistic role of PPAR gamma acetylation and asprosin - Research to be conducted in Old Westbury, NY - Estimated grant value is $428,400 - NAICS codes listed (237110, 541330) do not directly reflect the biomedical research focus, but are included in the solicitation - Period of Performance: - Four-year project duration

Description

This NIH grant opportunity aims to study the role of PPAR gamma acetylation and asprosin in obesity-related hypertension. The research involves in vivo, ex vivo, and in vitro approaches to understand the mechanisms involved. The project duration is from July 1, 2023, to June 30, 2027, with a total award amount of $428,400. The solicitation is open and responses are due by July 12, 2023.

View original listing